Novavax, Inc. (VIE:NVAX)
6.29
+0.06 (0.99%)
At close: Nov 12, 2025
Novavax Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1,065 | 682.16 | 983.71 | 1,982 | 1,146 | 475.6 | Upgrade | |
Revenue Growth (YoY) | 20.27% | -30.65% | -50.37% | 72.89% | 141.02% | 2448.48% | Upgrade |
Cost of Revenue | 432.03 | 569.64 | 1,037 | 2,071 | 2,535 | 747.03 | Upgrade |
Gross Profit | 632.62 | 112.52 | -53.55 | -89.48 | -1,388 | -271.43 | Upgrade |
Selling, General & Admin | 194.93 | 323.59 | 457.45 | 488.69 | 298.36 | 142.59 | Upgrade |
Research & Development | 20.87 | 20.87 | 41.21 | 66.57 | - | - | Upgrade |
Operating Expenses | 215.8 | 344.45 | 498.66 | 555.26 | 298.36 | 142.59 | Upgrade |
Operating Income | 416.82 | -231.93 | -552.21 | -644.74 | -1,687 | -414.02 | Upgrade |
Interest Expense | -30.11 | -20.08 | -14.42 | -19.88 | -21.13 | -15.15 | Upgrade |
Currency Exchange Gain (Loss) | 3.3 | -4.4 | 7.9 | -2.5 | -5.3 | 9.6 | Upgrade |
Other Non Operating Income (Expenses) | 46.77 | 44.84 | 30 | 13.47 | -1.53 | 4.01 | Upgrade |
EBT Excluding Unusual Items | 436.79 | -211.56 | -528.73 | -653.65 | -1,715 | -415.56 | Upgrade |
Merger & Restructuring Charges | -12.3 | -17 | -14.3 | - | - | -2.7 | Upgrade |
Gain (Loss) on Sale of Assets | -45.09 | 51.95 | - | - | - | - | Upgrade |
Pretax Income | 350.68 | -176.62 | -543.03 | -653.65 | -1,715 | -418.26 | Upgrade |
Income Tax Expense | 8.94 | 10.88 | 2.03 | 4.29 | 29.22 | - | Upgrade |
Net Income | 341.75 | -187.5 | -545.06 | -657.94 | -1,744 | -418.26 | Upgrade |
Net Income to Common | 341.75 | -187.5 | -545.06 | -657.94 | -1,744 | -418.26 | Upgrade |
Shares Outstanding (Basic) | 161 | 152 | 101 | 78 | 74 | 58 | Upgrade |
Shares Outstanding (Diluted) | 166 | 152 | 101 | 78 | 74 | 58 | Upgrade |
Shares Change (YoY) | 16.16% | 51.03% | 28.89% | 5.08% | 29.27% | 138.81% | Upgrade |
EPS (Basic) | 2.12 | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 | Upgrade |
EPS (Diluted) | 2.07 | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 | Upgrade |
Free Cash Flow | -383.74 | -100.32 | -767.74 | -504.99 | 268.45 | -97.01 | Upgrade |
Free Cash Flow Per Share | -2.31 | -0.66 | -7.62 | -6.46 | 3.61 | -1.69 | Upgrade |
Gross Margin | 59.42% | 16.50% | -5.44% | -4.52% | -121.10% | -57.07% | Upgrade |
Operating Margin | 39.15% | -34.00% | -56.14% | -32.53% | -147.13% | -87.05% | Upgrade |
Profit Margin | 32.10% | -27.49% | -55.41% | -33.20% | -152.12% | -87.94% | Upgrade |
Free Cash Flow Margin | -36.04% | -14.71% | -78.05% | -25.48% | 23.42% | -20.40% | Upgrade |
EBITDA | 451.83 | -183.44 | -510.99 | -615.68 | -1,674 | -409.13 | Upgrade |
EBITDA Margin | 42.44% | -26.89% | -51.94% | -31.07% | -146.03% | -86.02% | Upgrade |
D&A For EBITDA | 35.01 | 48.5 | 41.23 | 29.05 | 12.66 | 4.89 | Upgrade |
EBIT | 416.82 | -231.93 | -552.21 | -644.74 | -1,687 | -414.02 | Upgrade |
EBIT Margin | 39.15% | -34.00% | -56.14% | -32.53% | -147.13% | -87.05% | Upgrade |
Revenue as Reported | 1,065 | 682.16 | 983.71 | 1,982 | 1,146 | 475.6 | Upgrade |
Advertising Expenses | - | 33.7 | 91.5 | 84 | 8.9 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.